Cargando…
Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
Autores principales: | Dianzani, Chiara, Zara, Gian Paolo, Maina, Giovanni, Pettazzoni, Piergiorgio, Pizzimenti, Stefania, Rossi, Federica, Gigliotti, Casimiro Luca, Ciamporcero, Eric Stefano, Daga, Martina, Barrera, Giuseppina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7902146/ https://www.ncbi.nlm.nih.gov/pubmed/33644227 http://dx.doi.org/10.1155/2021/6158298 |
Ejemplares similares
-
Drug Delivery Nanoparticles in Skin Cancers
por: Dianzani, Chiara, et al.
Publicado: (2014) -
Interaction of aldehydes derived from lipid peroxidation and membrane proteins
por: Pizzimenti, Stefania, et al.
Publicado: (2013) -
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells
por: Cerbone, Angelo, et al.
Publicado: (2012) -
AS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells
por: Cerbone, Angelo, et al.
Publicado: (2012) -
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer
por: Pizzimenti, Stefania, et al.
Publicado: (2010)